HCC-1, a novel chemokine from human plasma

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• CC chemokines are crucial regulators of immune cell function.
• Previous research has identified various CC chemokines with distinct expression patterns and activities.
• The role of specific chemokines in chronic renal failure and hematopoiesis requires further elucidation.

Purpose of the Study:

• To isolate and characterize a novel CC chemokine, designated HCC-1, from patients with chronic renal failure.
• To investigate the expression profile, receptor usage, and functional activities of HCC-1.
• To determine the effect of HCC-1 on myeloid progenitor cell proliferation.

Main Methods:

• Isolation of HCC-1 from hemofiltrate of patients with chronic renal failure.
• Molecular cloning of HCC-1 cDNA from human bone marrow.
• Sequence analysis and comparison with known CC chemokines.
• Assessment of HCC-1 expression in normal human tissues and plasma.
• Functional assays using human monocytes, T lymphocytes, neutrophils, eosinophils, and CD34+ myeloid progenitor cells.

Main Results:

• HCC-1, a novel CC chemokine (8,673 Da, 74 amino acids), was isolated and its cDNA cloned.
• Mature HCC-1 shares 46% sequence identity with macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta.
• HCC-1 is constitutively expressed in various normal tissues and present at high concentrations in plasma.
• HCC-1 exhibits weak activity on monocytes, inducing Ca2+ changes and enzyme release but not chemotaxis.
• HCC-1 enhances CD34+ myeloid progenitor cell proliferation, comparable to MIP-1 alpha but less potent.

Conclusions:

• HCC-1 represents a novel CC chemokine with a unique expression pattern and functional properties.
• HCC-1 plays a role in regulating monocyte responses and significantly enhances myeloid progenitor cell proliferation.
• Further research into HCC-1's specific roles in immune responses and hematopoiesis is warranted.